bioRxiv Science⌕ Search

Biology subjects

Luka, G.

Publications and source records attributed to Luka, G..

2 recordsLinked to original sources

ColiFormer: A Transformer-Based Codon Optimization Model Balancing Multiple Objectives for Enhanced E. coli Gene Expression

Codon optimization has become a key strategy to improving heterologous gene expression in Escherichia coli. However, many existing methods focus primarily on maximizing the codon adaptation index (CAI) while overlooking the importance of codon harmonization, which is crucial for maintaining proper protein characteristics. In this study, we present ColiFormer, a transformer-based codon optimization framework that was fine-tuned on 3,676 high-expression E. coli genes curated from the NCBI database. Built upon the CodonTransformer BigBird architecture, ColiFormer employs self-attention mechanisms and a mathematical optimization method (the augmented Lagrangian approach) to balance multiple biological objectives simultaneously, including CAI, GC content, tRNA adaptation index (tAI), RNA stability, and minimization of negative cis-regulatory elements. Performance was evaluated on 37,053 native E. coli genes and 80 recombinant protein targets commonly used in industrial studies, and the results were compared with six established codon optimization approaches. Across all datasets, ColiFormer demonstrated significant improvements in CAI and tAI, maintained GC content within optimal ranges, and reduced the incidence of negative cis-regulatory elements, all with lower runtime costs than most alternative methods. These results, based on in silico metrics, indicate that ColiFormer consistently enhances recombinant protein expression and achieves superior performance across multiple benchmarks compared to other established techniques. The tool is available as an open-source software package, along with the benchmark sequences dataset used in this study.

bioinformatics↗

Remote-Controlled Wireless Bioelectronics for Fluoxetine Therapy to Promote Wound Healing in a Porcine Model

Wound healing presents a significant challenge in biomedical science, requiring precise therapeutic delivery and real-time monitoring. Bioelectronic systems offer a promising solution but remain largely unexplored for wound care, particularly in large animal models that reflect human healing dynamics. This study introduces a remote controlled wireless bioelectronic platform equipped with an iontophoretic pump to deliver fluoxetine, a selective serotonin reuptake inhibitor that promotes wound repair. In vitro and ex-vivo testing validated efficient on demand fluoxetine delivery. In vivo experiments in a porcine wound model demonstrated clear therapeutic efficacy over 3-day and 7-day periods. The system enhanced healing outcomes, increasing re-epithelialization by 37% (H&E staining), reducing the M1/M2 macrophage ratio by 33%, and stimulating neuronal growth at the wound site. This bioelectronic platform delivers fluoxetine in a controlled, remotely-controlled manner while allowing for wound direct wound imaging that can be used to monitor wound healing progress. Additionally, it allows precise dose and temporal delivery of treatment to enhance the outcome of future large animal wound healing studies.

bioengineering↗